Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




New Protocol Enables DNA Sequencing from Small or Degraded RNA Samples

By LabMedica International staff writers
Posted on 18 Apr 2011
A company with expertise in DNA and RNA sample preparation has joined forces with a major manufacturer of DNA sequencing equipment to develop a unique sample preparation method and high-throughput sequencing solution for small and degraded RNA samples.

454 Life Sciences (Branford, CT, USA), a subsidiary of Roche (Basel, Switzerland), and NuGEN Technologies (San Carlos, CA, USA) have developed a solution to the problem of working with limited amounts of sample material using both NuGEN's proprietary isothermal linear amplification (SPIA) products and the GS FLX Titanium cDNA Rapid Library Preparation protocol for the 454 GS Junior and GS FLX Systems for DNA sequencing.

"NuGEN's innovative sample preparation solutions provide a unique and powerful tool which will enable researchers to obtain high-quality data from their less abundant samples,” said Elizabeth Hutt, CEO of NuGEN Technologies. More...
"Together with 454 Sequencing Systems, the research community can perform whole transcriptome profiling on samples with as little as 500 pg of total RNA. Being able to collaborate with a leading NGS platform provider such as Roche, enables customers to leverage NuGEN's linear amplification technology while obtaining long and highly accurate sequence reads.”

"We are sensitive to the challenges many researchers face when working with precious and often irreplaceable samples,” said Dr. Todd E. Arnold, vice president of development at 454 Life Sciences. "By combining NuGEN's amplification technology with 454 Sequencing Systems, we provide a solution that meets these researchers' needs, while allowing them to leverage the power of 454 Sequencing System's long read lengths, which are critical for both de novo transcriptome assembly and comprehensive identification of splice variants and fusion transcripts.”

Related Links:
454 Life Sciences
Roche
NuGEN Technologies



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.